SN-6-DataSheet-生命科學(xué)試劑-MedChemExpress

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemESN 6Cat. No.: HY-107658CAS No.: 415697-08-4分式: CHNOS分量: 402.46作靶點(diǎn): Na+/Ca2+ Exchanger作通路: Membrane Transporter/Ion Channel儲存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 62.5 mg/mL (155.29

2、mM; Need ultrasonic)H2O : 40% PEG300 5% Tween-80 45% salineSolubility: 2.08 mg/mL (5.17 mM); Suspended solution; Need ultrasonic and warming2. 請依序添加每種溶劑： 10% DMSO 90% corn oilSolubility: 2.08 mg/mL (5.17 mM); Clear solution; Need warming1/2 Master of Small Molecules 您邊的抑制劑師www.MedChemEBIOLOGICAL ACT

3、IVITY物活性 SN 6種選擇性的 NCX 抑制劑，可抑制 NCX1，NCX2 和 NCX3 對 45Ca2+ 的吸收，IC50 值分別為 2.9，16和 8.6 M。IC50 & Target IC50：2.9 M (NCX1), 16 M (NCX2), 8.6 M (NCX3) 1體外研究 SN 6 is a selective Na+/Ca2+ exchanger inhibitor, which inhibits the initial rate of 45Ca2+ uptake into NCX1,NCX2, and NCX3 transfectants with IC50 va

4、lues of 2.9 0.12, 16 1.1, and 8.6 0.27 M. SN 6 (up to 30 M) also less potently inhibits muscarinic acetylcholine receptor, with a higher IC50 of 18 M. SN 6 (0.3-30 M) completely inhibits the initial rate of Na+i-dependent 45Ca2+ uptake into Na+-loaded sarcolemmalvesicles in a dose dependent manner (

5、IC50, 5.3 0.37 M). SN 6 (0.3-10 M) dose-dependently protectsagainst the hypoxia/reoxygenation-induced LDH release in parental LLC-PK1 cells and NCX1 transfectantsbut not in K229Q transfectants 1. SN 6 (1-30 M) suppresses the bidirectional outward and inward INCX ina concentration-dependent manner, w

6、ith IC50 values of 2.3 M and 1.9 M, respectively. SN 6 also inhibitsbidirectional current (INCX) in a Na+i concentration-dependent manner, with IC50 values of 3.4 M, 2.3 M,and 1.1 M at 10 mM, 20 mM, and 30 mM Na+i, respectively 2. SN 6 inhibits hypoxia/reoxygenation-induced LDH release with an IC50

7、value of 0.63 0.15 M in NCX1 transfectants 3.PROTOCOLCell Assay 1 Na+i-dependent 45Ca2+ uptake into cells expressing the wild-type or mutated exchangers are assayed. Inbrief, confluent transfectants in 24-well dishes are loaded with Na+ by incubation at 37C for 40 min in 0.5 mLof balanced salt solut

8、ion (BSS) (10 mM HEPES/Tris, pH 7.4, 146 mM NaCl, 4 mM KCl, 2 mM MgCl2, 0.1 mMCaCl2, 10 mM glucose, and 0.1% bovine serum albumin) containing 1 mM ouabain and 10 M monensin.45Ca2+ uptake is then initiated by switching the medium to Na+-free BSS (replacing NaCl with equimolarcholine chloride) or to n

9、ormal BSS, both of which contain 0.1 mM 45CaCl2 (370 kBq/mL) and 1 mM ouabain.After a 30-s incubation, 45Ca2+ uptake is terminated by washing cells four times with an ice-cold solutioncontaining 10 mM HEPES/Tris, pH 7.4, 120 mM choline chloride, and 10 mM LaCl3. Cells are thensolubilized with 0.1 N

10、NaOH, and aliquots are taken for determination of radioactivity and protein. Whenpresent, SN 6 and KB-R7943 are included in the medium 15 min before the start of 45Ca2+ uptake 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.REFERENCES1. Iwamoto T, et

11、al. The exchanger inhibitory peptide region-dependent inhibition of Na+/Ca2+ exchange by SN-6 2-4-(4-nitrobenzyloxy)benzylthiazolidine-4-carboxylic acid ethyl ester, a novel benzyloxyphenyl derivative. Mol Pharmacol. 2004 Jul;66(1):45-55.2. Niu CF, et al. Electrophysiological effects of SN-6, a novel Na+/Ca2+ exchange inhibitor on membrane currents in guinea pig ventricularmyocytes. Ann N Y Acad Sci. 2007 Mar;1099:534-9.3. Kita S, et al. Inhibitory mechanism of SN-6, a novel benzyloxyphenyl Na+/Ca2+ exchange inhibitor. Ann N Y Acad Sci. 2007Mar;1099:529-33.McePdfHeight Caution: Pro